by Dupuytren’s disease is a condition that causes the fingers to bend towards the palm of the hand. It is a progressive fibromatosis condition that involves the thickening and contraction of the fascia in the palm. Non-surgical treatment options such as needle fasciotomy, collagenase clostridium histolyticum (CCH) injection, radiation therapy, and steroid injections are increasingly being used to treat milder cases of the condition. The administration of CCH injections in particular has shown promising results in reducing finger contractures without surgery.
The Global Dupuytrens Disease Market is estimated to be valued at US$ 4.3 Bn in 2024 and is expected to exhibit a CAGR of 4.6% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Global Dupuytrens Disease are Endo International Plc, Bristol-Meyers Squibb Company, Spear Pharmaceuticals, GSK Plc., AstraZeneca, Hikma Pharmaceuticals Plc, LEO Pharma A/S, Fresenius Kabi AG, Bayer AG, Novartis AG, Pfizer Inc., Nantong Jinghua Pharmaceutical Co., Ltd., and Actiza Pharmaceutical Pvt. Ltd., 180 Life Sciences Corp.
The non-surgical treatment Global Dupuytrens Disease Market Trends represents a major growth opportunity due to the preference for minimally invasive treatments. Technological advances have led to the development of collagenase injections that provide an effective non-surgical option.
Advances in non-surgical treatment such as the introduction of CCH injections and radiation therapies have widened treatment options for milder cases of Dupuytren’s disease. These minimally invasive procedures help reduce finger contractures without extensive surgery.
Market Drivers
The global Dupuytren’s disease market is driven by the rising geriatric population globally as the condition is more prevalent in older age groups. As per estimates, around 30% of people over 60 and 50% of people over 80 are likely to develop Dupuytren’s disease. Chronic diseases such as diabetes that increase the risk of developing Dupuytren’s also contribute to market growth. Furthermore, the development of effective non-surgical treatments has increased accessibility and uptake of care, thereby boosting the market.
Current Challenges in Dupuytrens Disease Market
Dupuytrens disease is a condition that causes thick collagen cords and fibrosis to develop under the skin of the hands. The growing cords slowly contract the fingers and cause them to bend towards the palm, making it difficult to extend the fingers fully. Major challenges faced by the global Dupuytrens disease market are lack of curative treatment options, low awareness about disease management, and complex disease etiology. While some surgical procedures and collagenase injections are available to straighten the fingers, recurrence of contractures is a widely reported problem. Limited understanding of disease triggers such as genetics and environmental factors also hinders development of preventive solutions. Raising public knowledge to facilitate early diagnosis and treatment remains a key area needing attention.
SWOT Analysis
Strength: Non-surgical treatments like collagenase injections offer minimally invasive options; Awareness initiatives by patient advocacy groups help improve access to care.
Weakness: Complex pathogenesis delays development of curative therapies; High recurrence rates post-surgery hampers long term outcomes.
Opportunity: Further insights into disease biology can pave way for novel pharmacological interventions; Growth in healthcare expenditure boosts uptake of existing treatment modalities.
Threats: Limited efficacy and high cost of treatments restricts market growth in price sensitive regions; Risk of adverse effects with invasive procedures raise safety concerns.
Geographical Regions
North America commands major share of global Dupuytrens disease market in terms of value, led by favorable reimbursement structure, technological advances and concentration of key industry players in the region. On the other hand, Asia Pacific market is touted as the fastest growing regional market owing to rising disposable incomes, growing medical tourism and expansion of private healthcare sector in developing Asian countries.
India specifically holds immense future potential due to its large patient population and increasing disease burden. India accounts for over 300 million hand surgical procedures annually as per Indian Society for Surgery of the Hand, highlighting growing need for improved Dupuytrens disease management in the country.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it.
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
